Kimberly Schaff

Vancouver Island
Victoria, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer.

Real-world effectiveness of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and advanced melanoma at BC Cancer.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: March 03, 2026

Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.

Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: September 01, 2023

Real-world incidence of venetoclax toxicities in British Columbia.

Real-world incidence of venetoclax toxicities in British Columbia.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: March 07, 2022

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines.

Journal: Blood advances

Published: August 26, 2020

A real-world data approach to determine the optimal dosing strategy for pembrolizumab.

A real-world data approach to determine the optimal dosing strategy for pembrolizumab.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 17, 2020

Evaluation of the role of pharmacy technicians in reviewing the eligibility for Oncotype DX genomic test and the impact of the test on treatment plans in breast cancer patients.

Evaluation of the role of pharmacy technicians in reviewing the eligibility for Oncotype DX genomic test and the impact of the test on treatment plans in breast cancer patients.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: October 24, 2018

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.

Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 28, 2018

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.

Outcomes of Surgical and Chemotherapeutic Treatments of Goblet Cell Carcinoid Tumors of the Appendix.

Journal: Annals of surgical oncology

Published: October 19, 2017

Cancer referral and treatment activity 2010-2015: a population-based study from Vancouver Island.

Cancer referral and treatment activity 2010-2015: a population-based study from Vancouver Island.

Journal: Current oncology (Toronto, Ont.)

Published: January 05, 2017

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation.

Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 02, 2016

Adherence with capecitabine: A population-based analysis based on prescription refill data.

Adherence with capecitabine: A population-based analysis based on prescription refill data.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: November 02, 2016

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer.

Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer.

Journal: Current oncology (Toronto, Ont.)

Published: December 07, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026